KRAS and familial pancreatic carcinoma: Here, we outline emerging direct targeting and immunotherapeutic strategies, highlight results of corresponding preclinical and clinical trials in the context of lung, colorectal, and pancreatic cancer, and focus on clinical applications targeting oncogenic KRAS proteins.